Literature DB >> 15014178

CGRP-receptor antagonists--a fresh approach to migraine therapy?

Paul L Durham1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15014178     DOI: 10.1056/NEJMp048016

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

1.  The future of migraine: beyond just another pill.

Authors:  Roger K Cady
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

2.  Modelling the anti-migraine effects of BIBN 4096 BS: a new calcitonin gene-related peptide receptor antagonist.

Authors:  Iñaki F Trocóniz; Jan-Markus Wolters; Christiane Tillmann; Hans G Schaefer; Willy Roth
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  Synthesis and structure-activity relationship study of diaryl[d,f][1,3]diazepines as potential anti-cancer agents.

Authors:  Longjia Yan; Hui Wang; Yunpeng Chen; Zhiwei Li; Yazhong Pei
Journal:  Mol Divers       Date:  2018-01-03       Impact factor: 2.943

Review 4.  Calcitonin gene-related peptide (CGRP) and migraine.

Authors:  Paul L Durham
Journal:  Headache       Date:  2006-06       Impact factor: 5.887

Review 5.  Investigating endogenous peptides and peptidases using peptidomics.

Authors:  Arthur D Tinoco; Alan Saghatelian
Journal:  Biochemistry       Date:  2011-08-15       Impact factor: 3.162

6.  The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission.

Authors:  G A Lambert; J B Davis; J M Appleby; B A Chizh; K L Hoskin; A S Zagami
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-08-19       Impact factor: 3.000

Review 7.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

8.  Sensitization of primary afferent nociceptors induced by intradermal capsaicin involves the peripheral release of calcitonin gene-related Peptide driven by dorsal root reflexes.

Authors:  Dingge Li; Yong Ren; Xijin Xu; Xiaoju Zou; Li Fang; Qing Lin
Journal:  J Pain       Date:  2008-08-13       Impact factor: 5.820

9.  CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat.

Authors:  J Zeller; K T Poulsen; J E Sutton; Y N Abdiche; S Collier; R Chopra; C A Garcia; J Pons; A Rosenthal; D L Shelton
Journal:  Br J Pharmacol       Date:  2008-09-08       Impact factor: 8.739

10.  Methylene blue prevents osteoarthritis progression and relieves pain in rats via upregulation of Nrf2/PRDX1.

Authors:  Jia-Wei Li; Rong-Liang Wang; Jia Xu; Kuo-Yang Sun; Hui-Ming Jiang; Zi-Ying Sun; Zhong-Yang Lv; Xing-Quan Xu; Rui Wu; Hu Guo; Qing Jiang; Dong-Quan Shi
Journal:  Acta Pharmacol Sin       Date:  2021-04-08       Impact factor: 7.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.